Endo International (ENDP) Upgraded at BidaskClub
Endo International (NASDAQ:ENDP) (TSE:ENL) was upgraded by research analysts at BidaskClub from a “hold” rating to a “buy” rating in a report issued on Thursday.
Other equities analysts have also issued research reports about the company. Zacks Investment Research upgraded Endo International from a “hold” rating to a “buy” rating and set a $11.00 price target on the stock in a research note on Thursday, January 17th. Canaccord Genuity set a $17.00 price target on Endo International and gave the company a “buy” rating in a research note on Friday, March 8th. SunTrust Banks started coverage on Endo International in a research note on Tuesday. They issued a “buy” rating and a $13.00 price target on the stock. TheStreet lowered Endo International from a “c-” rating to a “d+” rating in a research note on Tuesday, November 27th. Finally, Piper Jaffray Companies reiterated a “hold” rating on shares of Endo International in a research note on Friday, March 1st. Fourteen research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Endo International has a consensus rating of “Hold” and an average target price of $15.44.
Endo International stock opened at $8.73 on Thursday. Endo International has a one year low of $5.27 and a one year high of $18.50. The firm has a market cap of $1.93 billion, a price-to-earnings ratio of 3.02 and a beta of 1.21.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. LS Investment Advisors LLC acquired a new stake in shares of Endo International during the 4th quarter valued at $59,000. Oregon Public Employees Retirement Fund acquired a new stake in shares of Endo International during the 4th quarter valued at $76,000. First Quadrant L P CA acquired a new stake in shares of Endo International during the 4th quarter valued at $92,000. Neuburgh Advisers LLC boosted its holdings in shares of Endo International by 13.9% during the 4th quarter. Neuburgh Advisers LLC now owns 24,860 shares of the company’s stock valued at $181,000 after acquiring an additional 3,036 shares in the last quarter. Finally, Neuberger Berman Group LLC acquired a new stake in shares of Endo International during the 3rd quarter valued at $202,000. 92.40% of the stock is currently owned by institutional investors.
About Endo International
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. The company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals, and International Pharmaceuticals.
Featured Story: How prevalent are 12b-1 fees?
Receive News & Ratings for Endo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endo International and related companies with MarketBeat.com's FREE daily email newsletter.